H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: A glimpse of the true relationship?

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Persson, Christina ^a   Jia, Yanbin ^a   Pettersson, Helena ^b   Dillner, Joakim ^a   Nyrén, Olof ^a   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE ANTIGEN; BACTERIAL ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; MALE; RISK FACTOR; SEROLOGY; STOMACH ADENOCARCINOMA; SWEDEN; ADOLESCENT; BLOOD; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; STOMACH TUMOR;

HELICOBACTER PYLORI;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 79952302672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017404     Document Type: Article

References (27)

1. Forman D, Burley VJ, (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20: 633-649.
2. Peek RM Jr, Blaser MJ, (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
3. Brenner H, Rothenbacher D, Arndt V, (2009) Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477.
4. Adamu MA, Weck MN, Gao L, Brenner H, (2010) Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 25: 439-448.
5. Malaty HM, Nyren O, (2003) Epidemiology of Helicobacter pylori infection. Helicobacter 8 (Suppl 1): 8-12.
6. de Vries AC, Kuipers EJ, (2007) Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter 12 (Suppl 2): 22-31.
7. Weiland O, Berg JV, Bottiger M, Lundbergh P, (1980) Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community. Scand J Infect Dis 12: 171-174.
8. Mattsson B, Wallgren A, (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23: 305-313.
9. Barlow L, Westergren K, Holmberg L, Talback M, (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48: 27-33.
10. Lauren P, (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49.
11. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, et al. (1991) Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol 29: 1635-1639.
12. Veijola L, Oksanen A, Sipponen P, Rautelin H, (2008) Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol 15: 1705-1710.
13. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, et al. (2008) Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 43: 1448-1455.
14. IARC, (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61: 1-241.
15. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ, (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94: 2373-2379.
16. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E, (2001) Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 48: 765-773.
17. Forman D, Webb P, Parsonnet J, (1994) H pylori and gastric cancer. Lancet 343: 243-244.
18. Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347-353.
19. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, et al. (2006) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98: 1445-1452.
20. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, et al. (1995) Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 48: 41-45.
21. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O, (1996) IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 67: 1-5.
22. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O, (2001) Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121: 784-791.
23. Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, et al. (2008) Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 123: 917-926.
24. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D, (2004) Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 159: 252-258.
25. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789.
26. Hsu PI, Lai KH, Hsu PN, Lo GH, Yu HC, et al. (2007) Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol 102: 725-730.
27. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H, (2010) Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control.